| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0017200 | Intron-Exon-Intron | chr10:31729045-31750166 | chr10:31440116-31461237 | 250 nt | 0.3680 |
| hsa_ZEB1_0017300 | Intron-Intron | chr10:31739177-31739665 | chr10:31450248-31450736 | 489 nt | 0.2638 |
| hsa_ZEB1_0018200 | Intron-Exon-Intron | chr10:31749966-31750712 | chr10:31461037-31461783 | 259 nt | 0.4440 |
| hsa_ZEB1_0017700 | Intron-Exon-Intron | chr10:31749966-31757459 | chr10:31461037-31468530 | 250 nt | 0.3360 |
| hsa_ZEB1_0018300 | Intron-Exon-Intron | chr10:31749966-31771587 | chr10:31461037-31482658 | 252 nt | 0.4087 |
| hsa_ZEB1_0017800 | Intron-Exon-Intron | chr10:31749966-31780699 | chr10:31461037-31491770 | 250 nt | 0.2720 |
| hsa_ZEB1_0018100 | Exon-Exon | chr10:31749966-31784767 | chr10:31461037-31495838 | 264 nt | 0.4545 |
| hsa_ZEB1_0018400 | Exon-Exon | chr10:31749966-31799803 | chr10:31461037-31510875 | 365 nt | 0.4055 |
| hsa_ZEB1_0018500 | Intron-Exon-Intron | chr10:31749966-31804317 | chr10:31461037-31515389 | 201 nt | 0.4279 |
| hsa_ZEB1_0017900 | Exon-Exon | chr10:31749966-31810864 | chr10:31461037-31521936 | 2546 nt | 0.4289 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].